Home/ Supplements/ Electrolytes/ Detox for Her

Detox for Her

product on market Capsule FoxyFit Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Detox for Her
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Potassium
18 mg (1% DV)
Cleanse Formula
1395 mg

Other Ingredients

Gelatin Silica Magnesium Stearate Titanium Dioxide Sodium Copper Chlorophyllin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions As a dietary supplement, take 1 capsule in the morning and 1 capsule in the evening. After assessing tolerance you may with to increase to 2 capsules in the morning and evening. Do not exceed more than 4 capsules per day.

Warnings & Precautions

Do not exceed more than 4 capsules per day.

Warning: Do not exceed the recommended dosage listed.

This product is not intended for use by any persons under age 18, who are pregnant or lactating, or have serious medical conditions.

This product is not intended for use by any persons under age 18, who are pregnant or lactating, or have serious medical conditions.

All persons should consult a physician before using dietary supplements, as individuals may have different supplement needs.

Keep out of reach of children.

Formulation Notes

Benefits Reduce bloating and water retention Promote weight loss and digestion Flush toxins and impurities Supports liver, kidney & gall bladder health

No Banned Substances

Natural cleanse & detox Flatten midsection Reduce bloating Flush toxins

Additional Information

Keep container tightly closed in a cool, dry place.

No Banned Substances Certified Good Manufacturing Practice cGMP Made in the USA

@Foxyfitsupplements Facebook Instagram

Metadata

Product Details

UPC / SKU0 19962 69013 6
DSLD Entry Date2023-12-14
Product TypeBotanical
FormCapsule
BrandFoxyFit
DSLD ID286866
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.